Received Aug 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
could not hear the sound; This serious case was reported by a consumer via interactive digital media and described the occurrence of deafness in a patient who received Herpes zoster (Herpes Zoster vaccine) for prophylaxis. On an unknown date, the patient received Herpes Zoster vaccine. On an unknown date, an unknown time after receiving Herpes Zoster vaccine, the patient experienced deafness (Verbatim: could not hear the sound) (serious criteria GSK medically significant). The outcome of the deafness was not reported. It was unknown if the reporter considered the deafness to be related to Herpes Zoster vaccine. The company considered the deafness to be unrelated to Herpes Zoster vaccine. Additional Information: GSK Receipt Date: 19-AUG-2025 This case was reported by a patient via interactive digital media. Patient could not hearth the sound.; Sender's Comments: A case of Deafness, on an unknown time after receiving Herpes Zoster vaccine, in a patient. Based on the available information a possible causality that the events were caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received